相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1
Leopold Kong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Overview of the CCP4 suite and current developments
Martyn D. Winn et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
Immunotherapeutic potential of neutralizing antibodies targeting conserved regions of the HCV envelope glycoprotein E2
Allan G. N. Angus et al.
FUTURE MICROBIOLOGY (2011)
Treatment Failure and Resistance with Direct-Acting Antiviral Drugs Against Hepatitis C Virus
Jean-Michel Pawlotsky
HEPATOLOGY (2011)
Mapping a Region of Hepatitis C Virus E2 That Is Responsible for Escape from Neutralizing Antibodies and a Core CD81-Binding Region That Does Not Tolerate Neutralization Escape Mutations
Zhen-Yong Keck et al.
JOURNAL OF VIROLOGY (2011)
Hepatitis C Virus Evasion Mechanisms from Neutralizing Antibodies
Caterina Di Lorenzo et al.
VIRUSES-BASEL (2011)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
Mutations within a Conserved Region of the Hepatitis C Virus E2 Glycoprotein That Influence Virus-Receptor Interactions and Sensitivity to Neutralizing Antibodies
Simrat Dhillon et al.
JOURNAL OF VIROLOGY (2010)
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
Paul Y. Kwo et al.
LANCET (2010)
The structural basis for autonomous dimerization of the pre-T-cell antigen receptor
Siew Siew Pang et al.
NATURE (2010)
The Disulfide Bonds in Glycoprotein E2 of Hepatitis C Virus Reveal the Tertiary Organization of the Molecule
Thomas Krey et al.
PLOS PATHOGENS (2010)
A reporter cell line for rapid and sensitive evaluation of hepatitis C virus infectivity and replication
Michaela Iro et al.
ANTIVIRAL RESEARCH (2009)
Identification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C Virus
Teresa J. Broering et al.
JOURNAL OF VIROLOGY (2009)
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
Alexander Ploss et al.
NATURE (2009)
Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Definition of a conserved immunodominant domain on hepatitis C virus E2 glycoprotein by neutralizing human monoclonal antibodies
Zhen-Yong Keck et al.
JOURNAL OF VIROLOGY (2008)
In vitro selection of a neutralization-resistant hepatitis C virus escape mutant
Meital Gal-Tanamy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Structural classification of CDR-H3 revisited: A lesson in antibody modeling
Daisuke Kuroda et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2008)
Crystal structure of human IPS-1/MAVS/VISA/Cardif caspase activation recruitment domain
Jane A. Potter et al.
BMC STRUCTURAL BIOLOGY (2008)
Determination of the human antibody response to the epitope defined by the hepatitis C virusneutralizing monoclonal antibody AP33
Alexander W. Tarr et al.
JOURNAL OF GENERAL VIROLOGY (2007)
Inference of macromolecular assemblies from crystalline state
Evgeny Krissinel et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
Matthew J. Evans et al.
NATURE (2007)
Antibody elbow angles are influenced by their light chain class
RL Stanfield et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33
AW Tarr et al.
HEPATOLOGY (2006)
Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies
JM Micallef et al.
JOURNAL OF VIRAL HEPATITIS (2006)
Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins
A Goffard et al.
JOURNAL OF VIROLOGY (2005)
Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein
A Owsianka et al.
JOURNAL OF VIROLOGY (2005)
Hepatitis C virus E2 has three immunogenic domains containing conformational epitopes with distinct properties and biological functions
ZY Keck et al.
JOURNAL OF VIROLOGY (2004)
Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor
B Bartosch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Analysis of antigenicity and topology of E2 glycoprotein present on recombinant hepatitis C virus-like particles
RF Clayton et al.
JOURNAL OF VIROLOGY (2002)
Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2
A Owsianka et al.
JOURNAL OF GENERAL VIROLOGY (2001)
Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding
AH Patel et al.
JOURNAL OF GENERAL VIROLOGY (2000)
Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes
KG Hadlock et al.
JOURNAL OF VIROLOGY (2000)
Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81
T Allander et al.
JOURNAL OF GENERAL VIROLOGY (2000)
分享论文
